3040 Federal Register / Vol. 61, No. 20 / Tuesday, January 30, 1996 / Notices

concentration of resources, decreased or

unfair competition, conflicts of

interests, or unsound banking

practices.’’ Any request for a hearing on

this question must be accompanied by

a statement of the reasons a written

presentation would not suffice in lieu of

a hearing, identifying specifically any

questions of fact that are in dispute,

summarizing the evidence that would

be presented at a hearing, and indicating

how the party commenting would be

aggrieved by approval of the proposal.

Comments regarding the application

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than February 13,

1996.

A. Federal Reserve Bank of Kansas

City (John E. Yorke, Senior Vice

President) 925 Grand Avenue, Kansas

City, Missouri 64198:

1. First Bankshares of Las Animan,

Inc., Las Animan, Colorado; to engage

de novo through its subsidiary,

Sunshine Village Apartments of Las

Animas, LTD, Las Animas, Colorado, in

the construction of 24-unit senior and

multi-family housing project, and

thereby engage in community

deveopment activities, pursuant to §

225.25(b)(6) of the Board’s Regulation Y.

The geographic scope for these activities

is Las Animas, Colorado.

Board of Governors of the Federal Reserve

System, January 24, 1996.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 96–1648 Filed 1–29–96; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

Agency Forms Submitted to the Office

of Management and Budget for

Clearance

The Department of Health and Human

Services, Office of the Secretary

periodically publishes a list of

information collections it has submitted

to the Office of Management and Budget

(OMB) for clearance in compliance with

the Paperwork Reduction Act of 1995

(44 U.S.C. Chapter 35) and 5 CFR

1320.5. The following are those

information collections recently

submitted to OMB.

1. Application for Correction of Public

Health Service Commissioned Corps

Records—0937–0095—Reinstatement

No Change—An application is

submitted by present and former PHS

Commissioned Corps officers to request

correction of an error or alleged

injustice in their personnel records.

The information submitted is used by

the Board for Correction to determine if

an error or injustice has occurred and to

rectify such error or injustice.

Respondents: Individuals; Annual

Number of Respondents: 8;

Average Burden per Response: four

hours; Frequency of response: singletime; Total Burden: 32 hours.

2. State Medicaid Fraud Control Units

Annual Report and Certification

Application (42 CFR 1007.15 and

1007.17)—0990–0162—Reinstatement

No Change—The program data required

of initial applicants to become certified,

and the annual reports required for

recertification are used by the Office of

Inspector General to ensure that Federal

matching funds are only expended for

allowable costs. In addition, the reports

are analyzed to monitor program

activities and determine whether

technical assistance is required.

Respondents: States; Burden

Information for New Applicants—

Number of Respondents: 2; Frequency

of Response: one-time; Burden per

Response: 112 hours; Burden for New

Applicants: 224 hours—Burden

Information for Recertification—

Number of Respondents: 45; Frequency

of Response: annually; Burden per

Response: 56 hours; Burden for

Recertification: 2520 hours—Total

Burden: 2744 hours.

OMB Desk Officer: Allison Eydt.

Copies of the information collection

packages listed above can be obtained

by calling the OS Reports Clearance

Officer on (202) 619–1053. Written

comments and recommendations for the

proposed information collection should

be sent directly to the OMB desk officer

designated above at the following

address: Human Resources and Housing

Branch, Office of Management and

Budget, New Executive Office Building,

Room 10235, 725 17th Street NW.,

Washington, D.C. 20503.

Dated: January 18, 1996.

Dennis P. Williams,

Deputy Assistant Secretary, Budget.

[FR Doc. 96–1633 Filed 1–29–96; 8:45 am]

BILLING CODE 4150–04–M

Notice of Interest Rate on Overdue

Debts

Section 30.13 of the Department of

Health and Human Services’ claims

collection regulations (45 CFR Part 30)

provides that the Secretary shall charge

an annual rate of interest as fixed by the

Secretary of the Treasury after taking

into consideration private consumer

rates of interest prevailing on the date

that HHS becomes entitled to recovery.

The rate generally cannot be lower than

the Department of Treasury’s current

value of funds rate or the applicable rate

determined from the ‘‘Schedule of

Certified Interest Rates with Range of

Maturities.’’ This rate may be revised

quarterly by the Secretary of the

Treasury and shall be published

quarterly by the Department of Health

and Human Services in the Federal

Register.

The Secretary of the Treasury has

certified a rate of 133⁄4% for the quarter

ended December 31, 1995. This interest

rate will remain in effect until such time

as the Secretary of the Treasury notifies

HHS of any change.

Dated: January 22, 1996.

George Strader,

Deputy Assistant Secretary, Finance.

[FR Doc. 96–1632 Filed 1–29–96; 8:45 am]

BILLING CODE 4150–04–M

Food and Drug Administration

[Docket No. 95N–0155]

Bio-Components, Inc.; Opportunity for

a Hearing on a Proposal to Revoke

U.S. License No. 1160

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

opportunity for a hearing on a proposal

to revoke the establishment license (U.S.

License No. 1160) and the product

licenses issued to Bio-Components Inc.

(BCI), for the manufacture of Source

Plasma and Source Leukocytes. The

proposed revocation is based on the

firm’s significant and continued

noncompliance with Federal biologics

regulations and standards included in

the firm’s license.

DATES: The firm may submit a written

request for a hearing to the Dockets

Management Branch by February 29,

1996, and any data and information

justifying a hearing by April 1, 1996.

Other interested persons may submit

written comments on the proposed

revocation by April 1, 1996

ADDRESSES: Submit written requests for

a hearing, any data and information

justifying a hearing, and any written

comments on the proposed revocation

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, rm. 1–23, 12420

Parklawn Dr., Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Timothy W. Beth, Center for Biologics

Evaluation and Research (HFM–635),